Jean-Frédéric Viret

Jean-Frederic Viret has extensive work experience in finance and leadership roles. Jean-Frederic is currently the Chief Financial Officer at Shasqi since February 2023. Prior to this, they served as the Chief Financial Officer at Blade Therapeutics, Inc. from March 2021 to November 2022, where they successfully built the finance team and played a key role in a merger with a SPAC. From September 2014 to March 2021, they held the position of Chief Financial Officer at Coherus BioSciences, where they were responsible for strategy, fundraising, and overseeing various departments. Before this, they served as the Chief Financial Officer at diaDexus, Inc. from February 2012 to September 2014 and at XDx, Inc. (now CareDx, Inc.) from December 2009 to January 2012. Jean-Frederic also worked as the President at JV Consulting from March 2009 to December 2009. Jean-Frederic gained experience in finance roles at Anesiva, Inc. from December 2002 to February 2009, where they eventually became the Vice President and Chief Financial Officer. Earlier in their career, they worked as an Associate Director of Finance at Tularik from March 2000 to November 2002 and as a Senior Associate at PricewaterhouseCoopers LLP from 1997 to 2000. Jean-Frederic started their career as a Post-doctoral Fellow at the Massachusetts Institute of Technology from 1993 to 1996.

Jean-Frederic Viret obtained their Ph.D. in Molecular Biology from the University of Strasbourg between 1989 and 1993. Jean-Frederic also completed a Visiting Fellowship in Molecular Biology at the Harvard Kenneth C. Griffin Graduate School of Arts and Sciences from 1988 to 1993. In 1996 and 1997, Viret pursued an MBA in Finance and Accounting at the Cornell Johnson Graduate School of Management. Though it is mentioned that they hold an inactive CPA certification, no further information is provided about the institution or year of certification.